MEDIA

News & Information

2026
2025
2024
2023
2022
2021
More years
2026-04-24
Chongqing Precision Biotech Recognized for Innovation at BIONNOVA Forum；Prof. Qian Cheng Highlights Advances in In Vivo CAR-T
April 22–23, 2026 — Chongqing Precision Biotech Co., Ltd. was recognized with the “Most Innovative Pharmaceutical Company” award at the 7th BIONNOVA Biopharmaceutical Innovators Forum, held at Zha...
Learn More +
2026-03-04
Chongqing Precision Biotech Announces Nature Cancer Publication of Phase 1 Data for Hypoxia-Responsive CEA-Targeted CAR-T Therapy in Solid Tumors
February 27, 2026 — Chongqing Precision Biotech Co., Ltd. announced that results from a Phase 1 clinical study of its internally developed hypoxia-responsive CEA-targeted CAR-T cell therapy (PC13) ha...
Learn More +
2026-01-21
CR/MRD-Negative Remission at Day 28: Initial Efficacy Results for First Patient Treated with Puzolcabtagene Autoleucel Injection in China
Recent advances in multi-agent chemotherapy have improved outcomes for pediatric and adolescent patients with B-cell acute lymphoblastic leukemia (B-ALL). However, patients with relapsed or refractory...
Learn More +
2026-01-15
Chongqing Precision Biotech Announces Puzolcabtagene Autoleucel Injection Selected Among Chongqing’s Top 10 Scientific and Technological Advances of 2025
the“Top 10 Scientific and Technological Advances of Chongqing in 2025.”
Learn More +
Previous 1 Next

FOLLOW US ON WECHAT

Building A, Gaoke Pioneer Park, Chuangye Avenue, Chongqing

+86(0)023-6817 7018

office@precision-biotech.com

© Copyright 2016-2025 重庆精准生物技术有限公司 All Rights Reserved

渝ICP备16003030号-1

渝公网安备 50010702505019号

 渝网药械信备字[2026]000022号 Design By:zhiing